Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 1

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 2

Conditions

Prostatic Neoplasms 3Colonic Neoplasms 3Breast Neoplasms 3Smoldering Multiple Myeloma 2Multiple Myeloma 2Monoclonal Gammopathy of Undetermined Significance 2Uterine Cervical Neoplasms 1Tuberous Sclerosis 1Stomach Neoplasms 1Seizures 1Locally Advanced Cervical Cancer 1Lennox Gastaut Syndrome 1Joint Diseases 1Esophageal Neoplasms 1Epilepsy 1Epilepsies, Myoclonic 1Colorectal Neoplasms 1Carcinoma, Intraductal, Noninfiltrating 1Cachexia 1Breast Carcinoma In Situ 1Arthralgia 1Adenomatous Polyposis Coli 1Aberrant Crypt Foci 1

Interventions

Curcumin 2Resistance Training 1Propranolol 1Probiotics 1Myelography 1Docosahexaenoic Acids 1Dietary Fiber 1Diet, Plant-Based 1Diet, Mediterranean 1Behavior Therapy 1Adrenergic beta-Antagonists 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Smoldering Multiple Myeloma × Curcumin × Clear all
NCT05640843 2026-04-16

A Study Comparing a Plant-Based Diet With Supplements and Placebo in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM)

Memorial Sloan Kettering Cancer Center

Phase NA Recruiting
180 enrolled
Plasma cell

Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance

NCT06055894 2025-11-13

A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)

Memorial Sloan Kettering Cancer Center

Phase NA Recruiting
200 enrolled
Plasma cell

Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡